Email updates

Keep up to date with the latest news and content from BMC Complementary and Alternative Medicine and BioMed Central.

Open Access Highly Accessed Research article

Antimicrobial activity of selected South African medicinal plants

Trine R H Nielsen13, Victor Kuete23*, Anna K Jäger1, Jacobus J Marion Meyer3 and Namrita Lall3*

Author Affiliations

1 Department of Medicinal Chemistry Faculty of Pharmaceutical Sciences, University of Copenhagen, Copenhagen, Denmark

2 Department of Biochemistry, Faculty of science, University of Dschang, P.O. Box 67, Dschang, Cameroon

3 Department of Plant Science, Faculty of Agricultural and Biological Science, Pretoria 0002, South Africa

For all author emails, please log on.

BMC Complementary and Alternative Medicine 2012, 12:74  doi:10.1186/1472-6882-12-74

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1472-6882/12/74


Received:19 January 2012
Accepted:14 June 2012
Published:14 June 2012

© 2012 Nielsen et al.; licensee Biomed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Nearly 3,000 plant species are used as medicines in South Africa, with approximately 350 species forming the most commonly traded and used medicinal plants. In the present study, twelve South African medicinal plants were selected and tested for their antimicrobial activities against eight microbial species belonging to fungi, Mycobacteria, Gram-positive and Gram-negative bacteria.

Methods

The radiometric respiratory technique using the BACTEC 460 system was used for susceptibility testing against Mycobacterium tuberculosis, and the liquid micro-broth dilution was used for other antimicrobial assays.

Results

The results of the minimal inhibitory concentration (MIC) determinations indicated that the methanol extracts from Acacia karoo, Erythrophleum lasianthum and Salvia africana were able to prevent the growth of all the tested microorganisms. All other samples showed selective activities. MIC values below 100 μg/ml were recorded with A. karoo, C. dentate, E. lasianthum, P. obligun and S. africana on at least one of the nine tested microorganisms. The best activity (MIC value of 39.06 μg/ml) was noted with S. africana against E. coli, S. aureus and M. audouinii, and Knowltonia vesitoria against M. tuberculosis.

Conclusion

The overall results of the present work provide baseline information for the possible use of the studied South African plant extracts in the treatment of microbial infections.

Background

The World Health Organization (WHO) estimates that up to 80% of the population in Africa makes use of traditional medicine as well as about 65% of the world's population [1]. Plants used in traditional medicine, also called phytomedicine are plant-derived medicines that contain chemicals, more usually, mixtures of chemical compounds that act individually or in combination on the human body to prevent disorders and to restore or maintain health [2]. With up to 19,581 indigenous species, South Africa has the richest temperate flora in the world. A minimum of 11,700 species are endemic to South Africa [3] and nearly 3,000 species are used as medicines with approximately 350 species forming the most commonly traded and used medicinal plants [4]. Hence, there is good reason to screen these traditionally used plants for new drug discovery. The ethnobotanical approach has a number of advantages when searching for new drug candidates. The plants have been ‘pre-screened’ through generations of trial and error processes occurring over hundreds or thousands of years [5]. This will result in a higher probability of producing useful therapies from a group of medicinal plants, and one can rationalize that any isolated active compounds from plants are likely to be safer than active compounds from plants with no history of human use [5,6]. The present work was therefore designed to investigate the antimicrobial activity of twelve selected South African medicinal plants, Acacia karroo Hayne (Mimosoideae), Acokanthera oppositifolia (Lam.) Codd (Apocynaceae), Bulbine latifolia (L.f.) Spreng var. Latifolia (Asphodelaceae), Curtisia dentata (Burm.f.) C.A.Sm. (Cornaceae), Erythrophleum lasianthum Corbishley (Caesalpinioideae), Knowltonia vesicatoria Sims (Ranunculaceae), Ptaeroxylon obliquum (Thunb.) Radlk. (Ptaeroxylaceae), Salvia africana-lutea L. (Lamiaceae), Sansevieria hyacinthoides Hort. ex Steud. (Dracaenaceae).

Methods

Plant materials and extraction

All plants were collected on the Campus area of the University of Pretoria in August 2007. The plant parts were mainly aerial parts such as leaves, stems and flowers, except for S. hyacinthoides where the rhizome was dug up and collected, based on the traditional uses (Table 1). The plants were then identified at the HGWJ Schweicherdt Herbarium, University of Pretoria and a voucher specimen was preserved there as well (Table 1). The air dried and powdered sample from each plant (10 g) were macerated in methanol (300 ml) for 48 h at room temperature with occasional shaking. After 48 hours the extract was filtered through a Whatmann no. 1 filter paper. The extract was then concentrated under reduced pressure to give the crude extracts. They were then kept at 4 °C until further use.

Table 1. Plants used in the present work

Chemicals for antimicrobial assay

Nystatin (Maneesh Pharmaceutic PVT) for fungi, ciprofloxacin and isoniazid (INH) (Sigma-Aldrich, Johannesburg, South Africa) for Mycobacterium smegmatis and M. tuberculosis respectively and gentamicin (Jinling Pharmaceutic Group corp.) for other bacteria were used as reference antibiotics (RA).

Microorganisms and culture media

The tested organisms included Mycobacterium smegmatis ATCC 700084 [obtained from South African Medical Research Council, Pretoria and authenticated by Professor Fanus Venter, Department of Microbiology and Plants Pathology, University of Pretoria], drug-susceptible strain of Mycobacterium tuberculosis H37Rv ATCC 27294 (America Type Culture Collection, Rockville, MD, USA), Methicillin-resistant Staphylococcus aureus (MRSA, LMP805) (Gram-positive bacterium), four Gram-negative bacteria namely β-lactamase positive (βL+) Escherichia coli (βL+EC, LMP701), Ampicillin-resistant Klebsiella pneumoniae (ARKP, LMP803), Carbenicillin-resistant Pseudomonas aeruginosa (CRPA, LMP804), Chloramphenicol-resistant Citrobacter (CRCF, LMP802) and two fungi namely Candida albicans (C. albicans LMP709U) and Microsporum audouinii (M. audouinii, LMP725D). M. smegmatis was cultured on Middlebrook 7 H11 agar and allowed to grow for 24 h. M. tuberculosis was plated on Löwenstein–Jensen medium and allowed to grow for 3–4 weeks at 37 °C. The 7 H9 broth was used to determine the minimal inhibition concentration (MIC) of the test samples on M. smegmatis and M. tuberculosis. Other microbial species were clinical isolates from Yaoundé General Hospital (Cameroon). Their identity was confirmed before use at the Laboratory of Applied Microbiology and Molecular Pharmacology (LMP) (Faculty of Science, University of Yaoundé I) by culturing on the specific media followed by biochemical test using API system as previously reported [13]. All the studied microorganisms were maintained on agar slant at 4 °C at the LMP. These strains were sub-cultured on a fresh appropriate agar plate 24 hours prior to any antimicrobial test. The Mueller Hinton broth (MHB) was used to determine the MIC of all samples against the tested pathogens. The MHB and Mueller Hinton Agar (MHA) were used to determine the minimal microbicidal concentration (MMC) of the active samples.

Microplate susceptibility testing against M. Smegmatis

All extracts were tested against M. smegmatis using the microplate dilution method. The MIC, MBC and bacteria preparation were performed in 96-well microplates as previously described [14,15]. The crude extracts were dissolved in 10% dimethylsulfoxide (DMSO) in sterile 7 H9 broth to obtain a stock concentration of 10 mg/ml. Serial two-fold dilutions of each sample to be evaluated were made with 7 H9 broth to yield volumes of 100 μl/well with final concentrations ranging from 19.53–2500 μg/ml. Ciprofloxacin served as the positive drug control. One hundred microlitre of M. smegmatis (0.2 log-phase, yielding 1.5 × 106 CFU/ml) were also added to each well containing the samples. The solvent control, DMSO at 2.5% or less in each well did not show inhibitory effects on the growth of M. smegmatis. Tests were done in triplicates. The cultured microplates were sealed with parafilm and incubated at 37 °C for 24 h. The MIC was detected following addition (40 μl) of 0.2 mg/ml p-iodonitrotetrazolium chloride (INT, Sigma-Aldrich) and incubated at 37 °C for 30 min [16,17]. Viable bacteria reduced the yellow dye to a pink color. MIC was defined as the lowest sample concentration that prevented this change and exhibited complete inhibition of bacterial growth. The MBC was determined by adding 50 μl aliquots of the preparations (without INT), which did not show any growth after incubation during MIC assays, to 150 μl of 7 H9 broth. These preparations were incubated at 37 °C for 48 h. The MBC was regarded as the lowest concentration of extract, which did not produce a color change after addition of INT as above mentioned.

Antitubercular rapid radiometric assay using mycobacterium tuberculosis

The radiometric respiratory technique using the BACTEC 460 system (Becton Dickinson Diagnostic Instrument, Sparks, MD) was used for susceptibility testing against M . tuberculosis as described previously [17-19] with some modifications. Solutions of all the samples were prepared in Dimethylsulfoxide (DMSO) to obtain a stock concentration. Control experiments showed that a final concentration of DMSO at 1% in the medium had no adverse effect on the growth of M. tuberculosis. The primary drug INH served as drug-control. A homogenous culture (0.1 ml of M. tuberculosis, yielding 1 × 104 to 1 × 105 CFU/ml) was inoculated in the vials containing samples as well as control vials [20]. Three sample-free vials were used as controls (medium + 1%DMSO); two vials (V1) were inoculated in the same way as the vials containing the sample, and one (V2) was inoculated with a 1:100 dilution of the inoculum (1:100 control) to produce an initial concentration representing 1% of the bacterial population (1 × 102 to 1 × 103 CFU/ml). Mycobacterium growing in 7 H12 medium containing 14 C labeled substrate (palmitic acid) uses the substrate and produced 14CO2. The amount of 14CO2 detected is expressed in terms of the growth index (GI) [21]. Vials were incubated at 37 °C and each was assayed everyday to measure the GI. On the Bactec TB-460 system, the GI is recorded on a scale of 0–999. Growth is detected when GI ≥ 20. Then the GI value of 10 represents the growth of 1% of the bacterial population, once the inoculum control reach 999. Therefore, the MIC was considered as the lowest concentration inhibiting more than 99% of the initial bacterial population. This was taken as the lowest concentration of the sample with recorded ΔG < 10. ΔG = Gx − G0; Gx being the GI of the treated medium on the day that control inoculum vial reach 999, G0 the GI at the first day of reading and ΔG, the difference between Gx and G0[22].

Antimicrobial assay on gram-positive, gram-negative bacteria and fungi

The MICs of crude extracts and reference antibiotics (RA) (gentamicin for bacteria and nystatin for fungi) were determined as follows: the test sample was first of all dissolved in dimethylsulfoxide (DMSO). The solution obtained was added to MHB to give a final concentration of 2500 μg/ml for the crude extracts and 78.12 for RA. This was serially diluted two fold to obtain concentration ranges of 19.53 to 2500 μg/ml for the crude extracts and 0.31 to 78.12 μg/ml for RA. One hundred microlitre of each concentration were added to each well (96- wells microplate) containing 95 μl of NBGP and 5 μl of inoculum (standardized at 1.5 106 CFU/ml by adjusting the optical density to 0.1 at 600 nm SHIMADZU UV-120-01 spectrophotometer) [23,24]. The final concentration of DMSO in the well was less than 1% (preliminary analyses with 1% (v/v) DMSO do not affect the growth of the test organisms). The negative control well consisted of 195 μl of MHB and 5 μl of the standard inoculum [23,24]. The plates were covered with a sterile plate sealer, then agitated to mix the contents of the wells using a plate shaker and incubated at 37 °C for 24 hours. The assay was repeated thrice. The effect of samples was detected following addition (40 μl) of 0.2 mg/ml p-iodonitrotetrazolium chloride and incubated at 37 °C for 30 min [25]. MIC and MMC were determined as above [23,24].

Results and discussion

The results of the antimicrobial activity of the studied plant extracts are summarized in Table 2 and 3. The results of the MIC determinations (Table 2) showed that the extracts from A. karoo, E. lasianthum stem and S. africana were able to prevent the growth of all the tested microorganisms. All other samples showed selective activities. Phytochemicals are routinely classified as antimicrobials on the basis of susceptibility tests that produce MIC in the range of 100 to 1000 µg/ml [25]. Activity is considered to be significant if MIC values are below 100 μg/ml for crude extract and moderate when 100 < MIC < 625 μg/ml [26,27]. Therefore, the activity recorded with A. karoo (leaves extract on C. albicans, M. audouinii and stem extract on M. audouinii and K. pneumoniae), C. dentate (leaves extract on C. albicans and stem bark extract on C. albicans and S. aureus), E. lasianthum on S. aureusP. obligun bark on E. coli and M. audouiniiS. africana on E. coli, S. aureus and M. audouinii and K. vesitoria aerial part on M. tuberculosis can be considered significant. The best activity was noted with S. africana, with the lowest MIC value of 39.06 μg/ml recorded on three of the nine microorganisms studied. Eight plant extracts found active against M. smegmatis were tested against M. tuberculosis (Table 2). Interestingly, they were also found to be active against M. tuberculosis, the best sample being the extract the aerial part of K. vesitoria (MIC of 39.06 μg/ml) and that from the bark of P. obligun (MIC of 156.25 μg/ml). However, it has been demonstrated that the sensitivity of M. tuberculosis is closer to that of M. smegmatis, a non pathogenic microorganism [15]. Therefore, this microorganism can be used for a preliminary study to select samples with potential activity against M. tuberculosis[15]. Hence, the results obtained herein are in accordance with such recommendation. Alternative criteria have been described by Fabry et al.[28], which consider extracts having MIC values below 8 mg/ml to have noteworthy antimicrobial activity. Under these less stringent criteria, the overall activity recorded with most of the studied extracts can be considered important. However, the tested samples were less active than the RA on all of the microbial strains, this observation been quite normal as it is expected that a crude extract (that contained a panel of both active and non active molecules) shows less activity than a purified compound. The results of the MMC determinations (Table 3) also showed that microbicidal effect of most of the active samples could be expected. The lowest MMC value below 100 μg/ml was recorded with S. africana, highlighting the good antimicrobial potency of this plant.

Table 2. Minimal inhibition concentration (μg/ml) of the crude extracts and reference antibiotics

Table 3. Minimal microbicdal concentration (μg/ml) of the crude extracts and reference antibiotics

The results of the present work can be considered important with regards to the medical importance of the studied microorganisms and the fact that most of them were found to be resistant to commonly used antibiotics. P. aeruginosa is an important nosocomial pathogen highly resistant to clinically used antibiotics, causing a wide spectrum of infections and leading to substantial morbidity and mortality [29]. Drug-resistant Enterobacteriaceae, including K. pneumoniaeE. aerogenes and E. coli, have also been classified as antimicrobial-resistant organisms of concern in healthcare facilities [30]. The activity of some of the extracts on M. smegmatis also suggested that an inhibition effect of this plant on M. tuberculosis could be expected as the sensitivity of this microbial species was found to be closer to M. smegmatis, a non pathogenic agent [15], and this hypothesis was confirmed herein.

Conclusion

The overall results of the present work provide baseline information for the possible use of South African plant extracts in the treatment of microbial infections involving resistant phenotypes.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

TRHN and VK carried out the study; TRHN, VK, AKJ, JJMM and NL designed the experiments; TRHN and VK wrote the manuscript; All authors read and approved the final manuscript.

Acknowledgement

Authors are thankful to the Medical Research Center, Pretoria, South Africa for its technical support.

References

  1. Fabricant DS, Farnsworth NR: The value of plants used in traditional medicine for drug discovery.

    Environ Health Persp 2001, 109:69-75. OpenURL

  2. Van Wyk B-E, Wink M: Medicinal Plants of the World. 1st edition. Briza Publications, Pretoria, South Africa; 2004. OpenURL

  3. Germishuizen G, Meyer NL, Steenkamp Y, Keith M: A checklist of South African plants. Southern African Botanical Diversity Network Report No. 41, Sabonet, Pretoria, South Africa; 2006. OpenURL

  4. Taylor JLS, Rabe T, McGaw LJ, Jäger AK, van Staden J: Towards the scientific validation of traditional medicinal plants.

    Plant Growth Regul 2001, 34:23-37. Publisher Full Text OpenURL

  5. Balick MJ: Ethnobotany and the identification of therapeutic agents from the rainforest. Ciba-Found-Symp, Wiley, Chichester ; 1990. OpenURL

  6. Khafagi IK, Dewedar A: The efficiency of random versus ethno-directed research in the evaluation of Sinai medicinal plants for bioactive compounds.

    J Ethnopharmacol 2000, 71:365-376. PubMed Abstract | Publisher Full Text OpenURL

  7. The International Plant Names Indexhttp://www.ipni.org webcite, (Accessed on November 21, 2007)

  8. Moffett RO: Name changes in the Old World Rhus and recognition of Searsia (Anacardiaceae).

    Bothalia 2007, 37:165-175. OpenURL

  9. Palgrave KC: Trees of Southern Africa. Cape Town, South Africa, Struik; 1988. OpenURL

  10. Neuwinger HD: African Ethnobotany – Poison and Drugs. Chapman & Hall, London, England; 1996. PubMed Abstract | PubMed Central Full Text OpenURL

  11. Watt JM, Breyer-Brandwijk MG: The medicinal and poisonous plants of Southern and Eastern Africa. Edinburg and London, England, E. & S. Livingstone LTD; 1962. OpenURL

  12. Johnson T: CRC Ethnobotany Desk Reference. CRC Press LLC, Boca Raton; 1999. OpenURL

  13. Mbaveng AT, Ngameni B, Kuete V, Simo IK, Ambassa P, Roy R, Bezabih M, Etoa FX, Ngadjui BT, Abegaz BM, Meyer JJ, Lall N, Beng VP: Antimicrobial activity of the crude extracts and five flavonoids from the twigs of Dorstenia barteri (Moraceae).

    J Ethnopharmacol 2008, 116:483-489. PubMed Abstract | Publisher Full Text OpenURL

  14. Salie F, Eagles PF, Leng HM: Preliminary antimicrobial screening of four South African Asteraceae species.

    J Ethnopharmacol 1996, 52:27-33. PubMed Abstract | Publisher Full Text OpenURL

  15. Newton SM, Lau C, Gurcha SS, Besra GS, Wright CW: The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria Canadensis.

    J Ethnopharmacol 2002, 79:57-67. PubMed Abstract | Publisher Full Text OpenURL

  16. Eloff JN: A sensitive a quick microplate method to dertermine the minimal inhibitory concentration of plant extracts for bacteria.

    Planta Med 1998, 64:711-713. PubMed Abstract | Publisher Full Text OpenURL

  17. Mativandlela SPN, Lall N, Meyer JJM: Antibacterial, antifungal and antitubercular activity of (the roots of) Pelargonium reniforme (CURT) and Pelargonium sidoides (DC) (Geraniaceae) root.

    S Afr J Bot 2006, 72:232-237. Publisher Full Text OpenURL

  18. Lall N, Meyer JJM: In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants,.

    J Ethnopharmacol 1999, 66:347-3549. PubMed Abstract | Publisher Full Text OpenURL

  19. Lall N, Meyer JJM: Antibacterial activity of water and acetone extracts of the roots of Euclea natalensis.

    J Ethnopharmacol 2000, 72:313-316. PubMed Abstract | Publisher Full Text OpenURL

  20. Heifets LB, Iseman MD, Cook JL, Lindhohlm LPJ, Drupa I: Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods.

    Antimicrob Agent Chemother 1985, 27:11-15. Publisher Full Text OpenURL

  21. Middlebrook G, Reggiardo Z, Tigertt WD: Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.

    Am Rev Respir Dis 1977, 115:1066-1069. PubMed Abstract OpenURL

  22. Kuete V, Mbaveng AT, Tsaffack M, Beng VP, Etoa FX, Nkengfack AE, Meyer JJ, Lall N: Antitumor, antioxidant and antimicrobial activities of Bersama engleriana (Melianthaceae).

    J Ethnopharmacol 2008, 115:494-501. PubMed Abstract | Publisher Full Text OpenURL

  23. Kuete V, Nguemeving JR, Beng VP, Azebaze AG, Etoa FX, Meyer M, Bodo B, Nkengfack AE: Antimicrobial activity of the methanolic extracts and compounds from Vismia laurentii De Wild (Guttiferae).

    J Ethnopharmacol 2007, 109:372-379. PubMed Abstract | Publisher Full Text OpenURL

  24. Kuete V, Simo IK, Ngameni B, Bigoga JD, Watchueng J, Kapguep RN, Etoa FX, Tchaleu BN, Beng VP: Antimicrobial activity of the methanolic extract, fractions and four flavonoids from the twigs of Dorstenia angusticornis Engl. (Moraceae).

    J Ethnopharmacol 2007, 112:271-277. PubMed Abstract | Publisher Full Text OpenURL

  25. Simões M, Bennett RN, Rosa EA: Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms.

    Nat Prod Rep 2009, 26:746-757. PubMed Abstract | Publisher Full Text OpenURL

  26. Kuete V: Potential of Cameroonian plants and derived products against microbial infections: a review.

    Planta Med 2010, 76:1479-1491. PubMed Abstract | Publisher Full Text OpenURL

  27. Kuete V, Efferth T: Cameroonian medicinal plants: pharmacology and derived natural products.

    Front Pharmacol 2010, 1:123. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  28. Fabry W, Okemo PO, Ansorg R: Antibacterial activity of East African medicinal plants.

    J Ethnopharmacol 1998, 60:79-84. PubMed Abstract | Publisher Full Text OpenURL

  29. Cardoso O, Alves AF, Leitão R: Surveillance of antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates from a central hospital in Portugal.

    J Antimicrob Chemother 2007, 60:452-454. PubMed Abstract | Publisher Full Text OpenURL

  30. Nicolle LE: Infection control programmes to contain antimicrobial resistance. World Health Organization. WHO/CDS/CSR/DRS, Geneva; 2001:7.

    http://whqlibdoc.who.int/hq/2001/WHO webcite CDS CSR DRS 2001.7.pdf, 2001, (accessed January 2009)

    OpenURL

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1472-6882/12/74/prepub